PPAR-delta modulators (Hillcrest)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePPAR-delta modulators (Hillcrest)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor delta modulators
TargetsPeroxisome proliferator-activated receptor delta
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInpharmatica Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHillcrest Therapeutics IncInpharmatica LtdGalapagos Nv
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A